シンポジウム

シンポジウム20 When and how do we decide to treat non-culprit lesion after ACS from the pathological ?

2019年9月20日(金) 09:40 〜 11:10 第2会場 (4号館1階)

座長:青木二郎(三井記念病院), Marco Roffi(University Hospitals of Geneva, Switzerland)

英語／同時通訳あり

[S20-K1] How to integrate the results of CULPRIT-SHOCK trial in clinical practice and what we shall expect from EURO-SHOCK trial

^○Marco Roffi (University Hospitals of Geneva, Switzerland)

^○Renu Virmani (CVPath Institute Inc., USA)

^○Pieter Smits (FESC, The Netherlands)

同通あり

^○Francesco Prati^1,2 (1.Cardiology Unit, San Giovanni, Hospital , Rome, 2.CLI Foundation – Rome)

同通あり

^○Davide Capodanno (Cardiology, AOU Policlinico-Vittorio Emanuele, University of Catania)

同通あり